Long-term Acyclovir Use to Prevent Recurrent Ocular Herpes Simplex Virus Infection
Authors:
- Renata A. RezendeRRRenata A. Rezende
- Maria A. CarrascoMCMaria A. Carrasco
- Christopher J. RapuanoCRChristopher J. Rapuano
- Peter R. LaibsonPLPeter R. Laibson
- Elisabeth J. CohenECElisabeth J. Cohen
- 1 December 2003
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 121 (12) , 1702-1704
Abstract
Research from JAMA Ophthalmology — Long-term Acyclovir Use to Prevent Recurrent Ocular Herpes Simplex Virus InfectionKeywords
This publication has 11 references indexed in Scilit:
- Indications for Penetrating Keratoplasty and Associated Procedures, 1996–2000Cornea, 2002
- Herpes Simplex Virus Epidemiology and Ocular ImportanceCornea, 2001
- Oral Acyclovir After Penetrating Keratoplasty for Herpes Simplex KeratitisArchives of Ophthalmology (1950), 1999
- Efficacy of low-dose and long-term oral acyclovir therapy after penetrating keratoplasty for herpes simplex heratitisOcular Immunology and Inflammation, 1999
- A Prospective Randomized Trial of Oral Acyclovir After Penetrating Keratoplasty for Herpes Simplex KeratitisCornea, 1994
- Long-term suppression of recurrent genital herpes with acyclovir. A 5-year benchmark. Acyclovir Study GroupArchives of Dermatology, 1993
- Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialisJournal of Medical Virology, 1993
- Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection. The Acyclovir Study Group1991
- Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trialJAMA, 1988
- Herpes Simplex Virus Types 1 and 2 in Ocular DiseaseArchives of Ophthalmology (1950), 1978